OBJECTIVES: Dried blood spots (DBS) and dried plasma spots (DPS) are considered convenient alternatives to serum and plasma for HIV drug resistance testing in resource-limited settings. We sought to investigate how extreme conditions could affect the short-term ability to amplify and genotype HIV from DBS. METHODS: A panel of six matched DPS/DBS was generated using blood collected from HIV-infected donors. Replicate cards were prepared in 903 filter paper using 50 microL of blood and stored at either -20 degrees C or at 37 degrees C/100% humidity. Nucleic acids were extracted at baseline and after 1, 2, 8 and 16 weeks of storage and were amplified and sequenced using an in-house RT-nested PCR method or the ViroSeq assay. RESULTS: HIV-1 pol was successfully amplified in all DBS/DPS at baseline and in those stored for up to 16 weeks at -20 degrees C by the in-house assay. In contrast, amplification was rapidly lost during storage at 37 degrees C/100% humidity with only 6/6 and 4/6 DBS specimens amplifiable by the in-house assay at weeks 1 and 2, respectively. Similarly, only two DPS stored at 37 degrees C/100% humidity were amplified by the in-house assay at week 1. CONCLUSIONS: We show that resistance testing from DBS and DPS is severely compromised after 2 and 1 weeks of storage at 37 degrees C/100% humidity with desiccant, respectively. These findings underscore the importance of temperature and humidity for the efficient genotyping of HIV-1 from DBS and DPS, and reiterate the need to rapidly transport specimens from collection sites to locations that have appropriate storage conditions such as -20 degrees C.
OBJECTIVES: Dried blood spots (DBS) and dried plasma spots (DPS) are considered convenient alternatives to serum and plasma for HIV drug resistance testing in resource-limited settings. We sought to investigate how extreme conditions could affect the short-term ability to amplify and genotype HIV from DBS. METHODS: A panel of six matched DPS/DBS was generated using blood collected from HIV-infected donors. Replicate cards were prepared in 903 filter paper using 50 microL of blood and stored at either -20 degrees C or at 37 degrees C/100% humidity. Nucleic acids were extracted at baseline and after 1, 2, 8 and 16 weeks of storage and were amplified and sequenced using an in-house RT-nested PCR method or the ViroSeq assay. RESULTS:HIV-1 pol was successfully amplified in all DBS/DPS at baseline and in those stored for up to 16 weeks at -20 degrees C by the in-house assay. In contrast, amplification was rapidly lost during storage at 37 degrees C/100% humidity with only 6/6 and 4/6 DBS specimens amplifiable by the in-house assay at weeks 1 and 2, respectively. Similarly, only two DPS stored at 37 degrees C/100% humidity were amplified by the in-house assay at week 1. CONCLUSIONS: We show that resistance testing from DBS and DPS is severely compromised after 2 and 1 weeks of storage at 37 degrees C/100% humidity with desiccant, respectively. These findings underscore the importance of temperature and humidity for the efficient genotyping of HIV-1 from DBS and DPS, and reiterate the need to rapidly transport specimens from collection sites to locations that have appropriate storage conditions such as -20 degrees C.
Authors: Silvia Bertagnolio; Luis Soto-Ramirez; Richard Pilon; Roberto Rodriguez; Monica Viveros; Luis Fuentes; P Richard Harrigan; Theresa Mo; Don Sutherland; Paul Sandstrom Journal: Antivir Ther Date: 2007
Authors: Silvia Bertagnolio; Inge Derdelinckx; Monica Parker; Joseph Fitzgibbon; Herve Fleury; Martin Peeters; Rob Schuurman; Deenan Pillay; Lynn Morris; Amilcar Tanuri; Guy-Michel Gershy-Damet; John Nkengasong; Charles F Gilks; Donald Sutherland; Paul Sandstrom Journal: Antivir Ther Date: 2008
Authors: Lisa A Spacek; Hasan M Shihab; Moses R Kamya; Doris Mwesigire; Allan Ronald; Harriet Mayanja; Richard D Moore; Michael Bates; Thomas C Quinn Journal: Clin Infect Dis Date: 2005-12-12 Impact factor: 9.079
Authors: Andrew J Buckton; Sara L Bissett; Richard E Myers; Simon Beddows; Simon Edwards; Patricia A Cane; Deenan Pillay Journal: J Antimicrob Chemother Date: 2008-10-16 Impact factor: 5.790
Authors: C M Parry; N Parkin; K Diallo; S Mwebaza; R Batamwita; J DeVos; N Bbosa; F Lyagoba; B Magambo; M R Jordan; R Downing; G Zhang; P Kaleebu; C Yang; S Bertagnolio Journal: J Clin Microbiol Date: 2014-05-28 Impact factor: 5.948
Authors: Mireia Arnedo; Elena Alonso; Nell Eisenberg; Laura Ibáñez; Cecilia Ferreyra; Angels Jaén; Laurence Flevaud; Samuel Khamadi; Paul Roddy; Jose Maria Gatell; David Dalmau Journal: PLoS One Date: 2012-12-06 Impact factor: 3.240
Authors: Emma M Harding-Esch; Martin J Holland; Jean-François Schémann; Sandra Molina; Isatou Sarr; Aura A Andreasen; Chrissy h Roberts; Ansumana Sillah; Boubacar Sarr; Edward F Harding; Tansy Edwards; Robin L Bailey; David C W Mabey Journal: PLoS Negl Trop Dis Date: 2011-08-02
Authors: Zhiyong Zhou; Nick Wagar; Joshua R DeVos; Erin Rottinghaus; Karidia Diallo; Duc B Nguyen; Orji Bassey; Richard Ugbena; Nellie Wadonda-Kabondo; Michelle S McConnell; Isaac Zulu; Benson Chilima; John Nkengasong; Chunfu Yang Journal: PLoS One Date: 2011-11-23 Impact factor: 3.240